Dow, S&P 500, Nasdaq Futures Trade Mixed With Bank Earnings On Deck

US stock futures were muted on Tuesday as crosscurrents from bank earnings, a chip sell-off, and volatile oil prices clouded the market outlook.

Futures on the Dow Jones Industrial Average (YM=F) rose by 0.2%, while those on the S&P 500 (ES=F) fell by 0.1%. Contracts for the Nasdaq-100 (NQ=F) declined by 0.6% as tech stocks continued to drag.

South Korea's KOSPI (^KS11) index fell 6%, weighed down by declines in memory stocks Samsung (005930.KS) and SK Hynix (000660.KS), as stocks in Asia extended Monday's chip sell-off. The pullback came after Chinese memory maker CXMT (688825.SS) announced progress on a new memory-cell design.

Adding to angst, Broadcom CEO Hock Tan likened investors speculating on AI to "a casino" on Monday. "A lot of investors have no clue what they are investing in," the chipmaker's CEO said, according to Bloomberg.

Attention also turned toward big bank earnings, which mark the unofficial start of the third quarter earnings season. JPMorgan Chase (JPM) reported weaker-than-expected profits, and Goldman Sachs (GS) and Citigroup (C) were also scheduled to report results on Tuesday morning.

Oil prices fell on Tuesday after Brent crude (BZ=F) topped $105 per barrel and gasoline prices tied 2022 for the most days above $4 per gallon in a single year.

Existing home sales are the primary data point to watch on Tuesday's economic calendar. But the main event will be inflation data later this week. Yahoo Finance reports.

🐄 ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026. Stock Up in Pre-Market

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures, and markets products to improve calf health and productivity, today announced preliminary, unaudited sales results for the third quarter of 2026.

“Total sales for the three months ended September 30, 2026, were $8.0 million, a 46.0% increase compared to the three months ended September 30, 2025. Domestic sales were $6.9 million, a 29.2% increase compared to 2025,” said Timothy Fiori, Chief Financial Officer of ImmuCell.

“We are pleased with the sales results experienced during the third quarter of 2026, while recognizing that our comparative sales growth was aided, in part, by depressed sales levels in the third quarter of 2025 caused by high distributor purchases in the second quarter of 2025. Total sales for the nine months ended September 30, 2026, were $25.6 million, a 27.8% increase compared to the nine months ended September 30, 2025.” GlobeNewswire reports.

🪪 BIO-key Adds New Middle East Government Security Agency Customer. Stock Rises in Pre-Market

BIO-key International, Inc. (Nasdaq: BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication, today announced that another Middle East government security agency, a new customer of the Company, has selected BIO-key’s Multi-Factor Authentication (MFA) and Single Sign-On (SSO) platform to strengthen its identity security.

BIO-key established a trusted relationship with the agency during the evaluation process by working to understand its operational priorities and long-term security objectives. The engagement progressed from initial discussions to an agreement in less than two months, reflecting close collaboration, executive alignment, and a shared commitment to strengthening identity security. GlobeNewswire reports.

🏥 Why UnitedHealth Group Shares are Trading Higher

Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply in pre-market trading after the company posted upbeat third-quarter results.

UnitedHealth Group reported quarterly earnings of $4.69 per share which beat the analyst consensus estimate of $4.15 per share. The company reported quarterly sales of $112.694 billion which beat the analyst consensus estimate of $111.403 billion.

UnitedHealth shares jumped 2.6% to $387.52 in pre-market trading. Benzinga reports.

🤖 Salesforce Buys AI Startup That Tells Businesses What's Going Wrong

Salesforce Inc. (NYSE: CRM) announced Monday that it signed a definitive agreement to acquire Loops, an artificial intelligence-powered analytics platform, as it expands Tableau’s AI capabilities.

Media reports value the deal at approximately $30 million. Salesforce did not disclose the financial terms.

Loops uses machine learning to monitor business performance, explain changes in key metrics, and identify opportunities for improvement.

The acquisition aims to strengthen Salesforce’s AI-driven analytics strategy by helping businesses understand performance trends and identify actions based on their data. Benzinga reports.

💾 Why is Sandisk Stock Falling Tuesday?

Sandisk Corp. (NASDAQ:SNDK) stock traded lower Tuesday by almost 4% as investors continued to weigh rising competition from China, softer flash-memory pricing and broader weakness across AI-linked semiconductor stocks.

The pressure follows Monday’s sharp selloff, when Sandisk erased about $15 billion in market value. Despite the pullback, the stock remains up almost 530% in 2026. Benzinga reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) BKYI: BIO-key International, Inc.
Total gain: +147.27%

2) TCRT: Alaunos Therapeutics, Inc.
Total gain: +108.57%

3) AIXI: Xiao-I Corporation
Total gain: +22.08%

4) IZEA: IZEA Worldwide, Inc.
Total gain: +13.92%

5) ICCC: ImmuCell Corporation
Total gain: +9.48%

The closing price of the top three market percent gainers trading near or above $2 on Oct 12.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) MNDR: Mobile-health Network Solutions
Total gain: +257.65%

The stock appeared to be moving on no notable news.

2) LNKS: Linkers Industries Limited
Total gain: +138.37%

The stock appeared to be moving on no notable news.

3) YMAT: J-Star Holding Co., Ltd.
Total gain: +125.58%

The stock appeared to be moving on no notable news.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

JNJ

Johnson & Johnson

Q3 2026

Before Market Open

Estimate: 2.530

Actual: 2.590

FBK

FB Financial

Q3 2026

Before Market Open

Estimate: 1.210

Actual: 1.210

UNTY

Unity Bancorp

Q3 2026

Before Market Open

Estimate: 1.550

Actual: 1.700

Time (ET) / Report / Period

• 6:00 AM / NFIB Index of Small Business Optimism / Sep
• 10:00 AM / Existing Home Sales / Sep
• 2:00 PM / Monthly Treasury Balance / Sep

“Investing is, at its heart, a very simple discipline. Simple, perhaps, but not easy.”

– Nick Sleep

Sourced in: Nomad Investment Partnership Letters.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.